Healthcare investment firm Patient Square Capital, has closed its inaugural fund with approximately $3.9 billion in total capital commitments, surpassing its $3 billion target, which the firm says makes it the largest first-time private equity fund ever raised, and the largest fund ever raised by a dedicated health-care-focused private equity, growth equity, or venture capital firm.Â
Healthcare investment firm Patient Square Capital (Patient Square), has closed its inaugural fund with approximately $3.9 billion in total capital commitments, surpassing its $3 billion target, which the firm says makes it the largest first-time private equity fund ever raised, and the largest fund ever raised by a dedicated health-care-focused private equity, growth equity, or venture capital firm.
Patient Square now has approximately $5.9 billion in total assets under management (AUM), including significant co-investment commitments from leading institutional investors.
Patient Square invests broadly across the health care industry, including development-stage therapeutics; commercial-stage pharmaceuticals; medical devices, diagnostics, and life science tools; health care providers; and technology-enabled and other services.
Since June 2021, Patient Square has deployed approximately $3 billion in equity capital, including significant co-investment commitments. The fund’s portfolio companies include Access Telecare, Apollo Therapeutics, Eargo, Enavate Sciences, Hanger Inc, Kriya Therapeutics, Radius Health, Resolve Biosciences, and Summit BHC.
